See more : Biotech Acquisition Company (BIOT) Income Statement Analysis – Financial Results
Complete financial analysis of Meihua International Medical Technologies Co., Ltd. (MHUA) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Meihua International Medical Technologies Co., Ltd., a leading company in the Medical – Instruments & Supplies industry within the Healthcare sector.
- Hi Sun Technology (China) Limited (HISNF) Income Statement Analysis – Financial Results
- Tega Industries Limited (TEGA.BO) Income Statement Analysis – Financial Results
- Armada Mercantile Ltd. (AAMTF) Income Statement Analysis – Financial Results
- Inter Industries Plus Ltd (ININ.TA) Income Statement Analysis – Financial Results
- TradeUP Global Corporation (TUGC) Income Statement Analysis – Financial Results
Meihua International Medical Technologies Co., Ltd. (MHUA)
About Meihua International Medical Technologies Co., Ltd.
Meihua International Medical Technologies Co., Ltd. engages in the manufacture and marketing of medical consumables in the People's Republic of China. It offers class I, II, and III disposable medical devices. The company's products include non-bottled products, such as brushes and ID bracelets; and polyethylene bottled products, such as eye drop and tablet bottles. It also distributes disposable medical devices sourced from other manufacturers to customers in China. The company serves hospitals, pharmacies, medical institutions, and medical equipment companies. It also exports its products to Europe, North America, South America, Asia, Africa, and Oceania. The company was founded in 1991 and is based in Yangzhou, the People's Republic of China. Meihua International Medical Technologies Co., Ltd. operates as a subsidiary of Bright Accomplish Limited.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 97.10M | 103.35M | 104.04M | 89.06M | 79.63M | 75.71M |
| Cost of Revenue | 64.00M | 65.25M | 64.23M | 51.90M | 47.42M | 43.82M |
| Gross Profit | 33.10M | 38.10M | 39.81M | 37.16M | 32.21M | 31.89M |
| Gross Profit Ratio | 34.08% | 36.86% | 38.26% | 41.72% | 40.45% | 42.12% |
| Research & Development | 2.75M | 2.96M | 2.73M | 2.49M | 3.21M | 2.87M |
| General & Administrative | 7.82M | 13.04M | 5.32M | 3.71M | 3.28M | 4.16M |
| Selling & Marketing | 7.30M | 5.64M | 6.46M | 6.62M | 5.41M | 5.67M |
| SG&A | 15.67M | 18.68M | 11.78M | 10.34M | 8.68M | 9.85M |
| Other Expenses | 1.00 | 898.66K | -50.44K | 864.79K | 926.20K | 0.00 |
| Operating Expenses | 18.42M | 22.54M | 14.50M | 13.69M | 12.82M | 13.10M |
| Cost & Expenses | 82.42M | 87.79M | 78.74M | 65.59M | 60.24M | 56.92M |
| Interest Income | 873.44K | 63.73K | 23.86K | 36.58K | 48.84K | 77.42K |
| Interest Expense | 250.78K | 194.67K | 180.74K | 137.16K | 97.79K | 0.00 |
| Depreciation & Amortization | 470.99K | 563.46K | 622.47K | 523.43K | 509.22K | 567.77K |
| EBITDA | 15.77M | 16.12M | 26.88M | 23.99M | 19.90M | 19.74M |
| EBITDA Ratio | 16.24% | 15.61% | 24.89% | 26.95% | 25.05% | 26.08% |
| Operating Income | 14.67M | 15.57M | 25.30M | 23.47M | 19.39M | 19.18M |
| Operating Income Ratio | 15.11% | 15.06% | 24.32% | 26.35% | 24.35% | 25.33% |
| Total Other Income/Expenses | 373.84K | 89.29K | -32.91K | 267.35K | -137.69K | -465.98K |
| Income Before Tax | 15.05M | 10.89M | 25.27M | 23.73M | 19.25M | 18.71M |
| Income Before Tax Ratio | 15.50% | 10.54% | 24.29% | 26.65% | 24.18% | 24.72% |
| Income Tax Expense | 3.46M | 4.71M | 5.28M | 4.69M | 3.82M | 3.23M |
| Net Income | 11.63M | 6.24M | 20.95M | 19.05M | 15.43M | 15.48M |
| Net Income Ratio | 11.97% | 6.04% | 20.14% | 21.38% | 19.38% | 20.44% |
| EPS | 0.49 | 0.27 | 0.89 | 0.79 | 0.64 | 0.77 |
| EPS Diluted | 0.49 | 0.27 | 0.89 | 0.79 | 0.64 | 0.77 |
| Weighted Avg Shares Out | 23.94M | 23.41M | 23.60M | 24.14M | 24.14M | 20.00M |
| Weighted Avg Shares Out (Dil) | 23.94M | 23.41M | 23.60M | 24.14M | 24.14M | 20.00M |
Meihua International Medical Technologies Co., Ltd Stock Up 4.80% Since IPO
Source: https://incomestatements.info
Category: Stock Reports